Concentric Capital Strategies, LP Merck & Co., Inc. Transaction History
Concentric Capital Strategies, LP
- $2.38 Billion
- Q3 2024
A detailed history of Concentric Capital Strategies, LP transactions in Merck & Co., Inc. stock. As of the latest transaction made, Concentric Capital Strategies, LP holds 13,123 shares of MRK stock, worth $1.3 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
13,123
Previous 7,684
70.78%
Holding current value
$1.3 Million
Previous $951,000
56.68%
% of portfolio
0.06%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding MRK
# of Institutions
3,827Shares Held
1.87BCall Options Held
15.6MPut Options Held
13.7M-
Vanguard Group Inc Valley Forge, PA250MShares$24.8 Billion0.52% of portfolio
-
Black Rock Inc. New York, NY207MShares$20.6 Billion0.59% of portfolio
-
State Street Corp Boston, MA119MShares$11.8 Billion0.56% of portfolio
-
Wellington Management Group LLP Boston, MA75.8MShares$7.52 Billion1.55% of portfolio
-
Geode Capital Management, LLC Boston, MA59.2MShares$5.87 Billion0.55% of portfolio
About Merck & Co., Inc.
- Ticker MRK
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,533,280,000
- Market Cap $251B
- Description
- Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...